The classic website will no longer be available as of June 25, 2024. Please use the modernized ClinicalTrials.gov.

Say goodbye to the classic ClinicalTrials.gov!

The classic ClinicalTrials.gov website will be retired on June 25, 2024. Please use the modernized ClinicalTrials.gov. For more information, see ClinicalTrials.gov Modernization.

Key Record Dates

ClinicalTrials.gov Identifier:	NCT04879628
Brief Title:	Proof-of-concept Study for SAR441344 (Frexalimab) in Relapsing Multiple Sclerosis

First Submitted :	May 6, 2021
First Submitted that Met QC Criteria :	May 6, 2021
First Posted :	May 10, 2021

Certification/Extension First Submitted :	September 21, 2023
Certification/Extension First Posted :	September 28, 2023

Last Update Submitted that Met QC Criteria :	February 18, 2024
Last Update Posted :	February 21, 2024

To Top